New opportunities on the horizon as TSS expands US operations

We are expanding our US operations, with Evan Hahn to be the new VP North America. Evan brings a wealth of knowledge of the pharmaceutical clinical trial space, supporting the TSS launch of its new offering in this category.
TSS recently appointed of Evan Hahn as VP of North America to lead expansion in the strategic US life sciences market.

TSS expands US operations

Evan brings extensive expertise and over 20 years of experience applying innovative approaches to life sciences through a combination of technology and sophisticated applications of data, driving insights and efficiency in clinical development.

Before joining TSS, Evan led the growth of Medidata’s Randomization and Trial Supply software solution (RTSM) from product startup to an industry leader. At Cytel, he promoted the adoption of adaptive trial designs and drug supply forecasting. Across both organizations, he met with 100s of supply chain leaders globally, gaining broad insights into the challenges they face, receiving feedback from large pharma, startup biotechs, CROs, and regulatory agencies such as the FDA and NCI on biopharma supply challenges.

Evan explains the reason for his move to TSS: “Temperature monitoring plays a vital role in the drugs delivery cycle – and TSS is at the cutting edge of ensuring the delivery of safe and sustainable therapies to patients. I’m passionately committed to bringing innovative approaches to developing and delivering treatments and see tremendous opportunities to harness supply chain data into actionable insights – opportunities that are currently under-realized within biopharma.”

TSS’s technology-agnostic cloud platform is a ‘best in class’ solution that enables companies to transform their supply chain, by allowing for the ingestion and aggregation of data from disparate sources across that chain, providing end-to-end visibility and enabling direct to patient clinical trials while ensuring patient safety. Through advanced analytics and visualization of data we let users proactively address issues before they occur. With our Clinical Module, TSS is uniquely positioned to automate manual temperature excursion handling processes, and as such reduce burden for clinical sites and sponsor companies, while contributing to corporate sustainability goals.

For further information, please contact Matias Rodriguez, Head of Marketing. matias.rodriguez@tss.se

You may also be interested in

A speaker at the LogiPharma conference presents on 'Reactive Excursion Intervention with Real-Time Temperature Data,' illustrating the importance of proactive temperature management for a resilient pharma supply chain.

Proactive Temperature Management: The Key to a More Resilient Pharma Supply Chain

At this year's LogiPharma Europe 2025 in Lyon, Anita Leposa, Key Account Manager at TSS, and Neil Malkin, Business Process Owner for Temperature Management at AstraZeneca, took the stage to discuss one of the most pressing challenges in the pharmaceutical supply chain: temperature excursions and their impact on medicine availability.
Read moreDownload Whitepaper

Responsible Minerals Sourcing Policy

Read moreDownload Whitepaper
A TSS banner for LogiPharma Lyon 2024, showcasing automated temperature monitoring solutions for the pharmaceutical industry.

LogiPharma Lyon 2024

The Future of Temperature Monitoring: How to lower the CO2 footprint with a Circular Supply Solution
Read moreDownload Whitepaper

You may also be interested in

Freezer for temperature monitoring.

Achieving FDA and EMA Compliance in Temperature Monitoring

Many pharmaceuticals and biological products require specific temperature conditions during manufacturing, storage, and transport to ensure their quality and safety. Failure to maintain these conditions can lead to product degradation, making them less effective or even dangerous. To protect public health, regulatory authorities like the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) have established strict guidelines to manage these products. To comply with these regulations, life science companies must adopt advanced temperature monitoring systems that can track and record conditions continuously and reliably. This whitepaper explains the main requirements from both the FDA and EMA, the role of technology in maintaining compliance, and the best practices for setting up effective temperature monitoring systems.
Read more

TSS launches innovative Bluetooth powered temperature monitoring solutions

TSS introduces a new era of efficiency, with next-generation Bluetooth Low Energy temperature monitoring solutions that help life science supply chain professionals automate their processes for time and cost savings while securing patient safety.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.